Abstract
A distinction has traditionally been made in oncology between locally limited and systemically metastasized disease stages, in which local therapies pursued a curative or palliative goal. The term oligometastasis describes a vaguely defined intermediate stage in which randomized studies have demonstrated survival benefits of selected patient groups by using local ablative techniques. Currently, oligometastasis is defined by a limited number of metastases and affected organ systems independent of the tumor entity. Classical empirical evidence of the biological aggressiveness of metastasized tumors, such as disease-free interval or response to chemotherapy is not found in current recommendations. The biological Background: of a limited metastatic capacity is insufficiently understood as is the detection by biomarkers or gene expression profiles in order to be able to make an even more precise patient selection for a local therapeutic approach in addition to an optimal systemic therapy.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Fakultät: | Medizin |
Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
ISSN: | 0947-8965 |
Sprache: | Deutsch |
Dokumenten ID: | 85362 |
Datum der Veröffentlichung auf Open Access LMU: | 25. Jan. 2022, 09:13 |
Letzte Änderungen: | 25. Jan. 2022, 09:13 |